Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek!
Nieuwsfeed
- COREON Jaarverslag 2020
- Regeneron halts placebo enrollment in Covid-19 cocktail trial after IDMC finds 'clear' efficacy — but there are no data yet
- NOW AVAILABLE: Space Studies Board Annual Report 2019
- Vijf jaar Wkkgz: hier valt nog winst te behalen
- Longevity pharmacology comes of age
- A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system
- Challenges and opportunities in the discovery, development, and commercialization of pathogen-targeted antibiotics
- Coronabesmettingen stijgen sterk sinds maandag
- S&P expects steady erosion in Big Pharma's credit profile in 2021 as new M&A deals roll in — but don't underestimate their underlying strength
- Potential and promising anticancer drugs from adenosine and its analogs
- Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art
- Stakeholder survey on how the Due Diligence Ready! portal can offer support
- FDA investiga infección cerebral poco común en paciente que tomó Gilenya (fingolimod)
- CMO Tal Zaks bids Moderna a surprise adieu as biotech projects $18.4B in revenue, plots post-Covid expansion
- CMO Tal Zaks bids Moderna adieu as biotech projects $18.4B in revenue, plots post-Covid expansion
- UNICEF Innocenti | Research News | February 2021
- Dutch biotech Intravacc seeks to bolster Netherlands vaccine manufacturing abilities with new plants
- Examination Statements or Certificate of Suitability for an Examining Institution (VGO)
- Follow biotechs going public with the Endpoints News' IPO Tracker
- Royal Decree – Uploading files in 2021
- Register for today's discussion on mental health during a pandemic
- Vooraankondiging subsidieronde FMS kennishiaten op het gebied van behandeling COVID-19
- Patent Certifications and Suitability Petitions
- Office of Pharmaceutical Manufacturing Assessment
- Ghana is first African country to receive COVID-19 vaccines from COVAX
- Merck takes a swing at the IL-2 puzzlebox with a $1.85B play for buzzy Pandion and its autoimmune hopefuls
- The RW Daily: Nanotech group that retracted Nature study pulls two more papers. And "some universities are mishandling allegations of misconduct."
- International cooperation to align approaches for regulation of COVID-19 vaccines and medicines, , 25/02/2021
- Sean Nolan gathers AveXis alumnis to launch another biotech. Is it another race-to-IPO?
- Covid-19 roundup: Pfizer/BioNTech shot just as effective in real world, study says, as pair preps variant booster shots
- Biden is looking beyond Woodcock or Sharfstein for FDA commissioner — report
- Xencor and UCLA TDG partner to develop therapeutic antibodies
- GlaxoSmithKline rethinks strategy for Covid-19 antibody — not the Vir ones — after trial flop. Is there hope in high-risk patients?
- Flagship upstart Cellarity gathers $123M to finance its exploration of cell behavior, blazing a new path to building a broad pipeline
- Blog alert - PART 3: Understanding the pandemic – What has lockdown meant for ‘families beyond households’?
- Nanotech group that retracted Nature study pulls two more papers
- Zorgmijding door coronacrisis blijft beperkt, maar was slechte beslissing
- Taking aim at coronavirus variants, how to find vaccine, & hospital chaplains balancing safety with patients' spiritual needs
- Moderna's Covid-19 booster plan, J&J's day at the FDA, & consolidation among the contractors
- 80.000 medewerkers wijkverpleging aan de beurt voor coronavaccin
- TrialSite News Daily Digest
- Registration now open for RDA's 17th Plenary Meeting
- What’s Next for Open Science — Making the Case for Open Methods
- Newcells Biotech receive £5m to boost liver and lung condition research
- NICE issues draft guidance recommending sapropterin for PKU in children
- EuropaBio Newsletter N. 7 of 2021
- Machine learning and big data are unlocking Europe’s archives
- New research article confirms role of masitinib as a potential pancreatic cancer therapy
- Barec Board Elections
- Eén jaar corona in Nederland: Tilburg herdenkt en eert ‘helden’